미디어

  • 2019
  • 2016
  • 2015
  • 2014

Exhibitors Inventions

Seoul International Invention Fair
SIIF 는 전문적인경험과 지식을 가지고 있으며
성공적인 발명전시회를 개최할 수 있도록 노력하겠습니다.
Exhibitors inventions 게시글의 상세 화면
Title Coumarin derivatives as Nrf2 protein activator
Department Medical Technology/Medical/Health/Cosmetics Year 2014
Company Tajen University Regist No Patent No: R.O.C. 102134244 Date 2014-12-15
Chemoprevention is one of the important areas of cancer prevention research. Among all the approaches, activate the phase ?? metabolic enzymes biotransformation activity against the carcinogens results blocking or inhibiting cancer development process is most active investigation area. Nrf2 protein is the key transcription factor for induction the phase ?? metabolic genes expression, therefore, to develop different Nrf2-activators will provide a new strategies for anti-cancer treatment. Most of coumarin derivatives show various biological activity, such as antibiotic (novobiocin), anticoagulant(dicoumarol, warfarin), and rodenticides(warfarin). Recently studies also shown that the functional groups, the ??, ??-unsaturated ketone, might activate the Nrf2-signaling pathway, therefore, various coumarin-derivatives were synthesized and tested Nrf2-activation ability in our laboratory.
Exhibitors inventions 게시판의 이전글 다음글
이전글 Preview The preparation of naphthol derivatives that could re-sensitize chemo-resistant cancer toward chemo-therapeutic agent
이전글 Next Adjustable stethoscope
SIIF 2020 Seoul International Ivention Fair 2020
Korea Intellectual Property Service Center 17F, 131 Teheran-ro, Gangnam-gu, Seoul, Republic of Korea 06133
TEL : +82-2-3459-2843 / 2924   EMAIL : siif@kipa.org